X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6251) 6251
Publication (905) 905
Book Chapter (89) 89
Book Review (59) 59
Book / eBook (26) 26
Conference Proceeding (15) 15
Web Resource (10) 10
Dissertation (9) 9
Magazine Article (7) 7
Newsletter (7) 7
Reference (2) 2
Government Document (1) 1
Newspaper Article (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4577) 4577
index medicus (3672) 3672
hematology (2926) 2926
female (1997) 1997
male (1993) 1993
myeloproliferative neoplasms (1945) 1945
mutation (1851) 1851
oncology (1843) 1843
middle aged (1589) 1589
polycythemia-vera (1560) 1560
essential thrombocythemia (1508) 1508
aged (1445) 1445
myeloproliferative disorders (1431) 1431
myeloproliferative disorders - genetics (1324) 1324
adult (1305) 1305
janus kinase 2 - genetics (1271) 1271
myelofibrosis (1101) 1101
leukemia (1038) 1038
animals (894) 894
aged, 80 and over (780) 780
jak2 (765) 765
genetic aspects (758) 758
tumors (695) 695
tyrosine kinase jak2 (634) 634
prognosis (630) 630
cancer (612) 612
hemic and lymphatic diseases (610) 610
myeloproliferative disorders - pathology (586) 586
polycythemia vera (582) 582
diagnosis (569) 569
primary myelofibrosis (566) 566
mice (554) 554
research (554) 554
myeloproliferative disorders - diagnosis (535) 535
myeloproliferative neoplasm (516) 516
risk factors (503) 503
acute myeloid-leukemia (502) 502
analysis (470) 470
care and treatment (465) 465
disorders (457) 457
myelodysplastic syndromes (447) 447
abridged index medicus (444) 444
adolescent (433) 433
young adult (421) 421
pathology (415) 415
thrombosis (415) 415
article (407) 407
neoplasms (403) 403
primary myelofibrosis - genetics (398) 398
thrombocythemia, essential - genetics (394) 394
myeloproliferative disorders - drug therapy (391) 391
gene mutations (385) 385
mutations (375) 375
bone marrow (374) 374
myeloid metaplasia (372) 372
health aspects (366) 366
hematology, oncology and palliative medicine (366) 366
treatment outcome (361) 361
cell biology (360) 360
medicine & public health (351) 351
signal transduction (345) 345
ruxolitinib (344) 344
polycythemia vera - genetics (342) 342
janus kinase 2 (334) 334
stem cells (330) 330
bone marrow - pathology (326) 326
janus kinase 2 - metabolism (317) 317
myeloproliferative disorders - complications (317) 317
janus kinase 2 - antagonists & inhibitors (309) 309
chronic myeloid-leukemia (300) 300
chronic myelomonocytic leukemia (300) 300
retrospective studies (299) 299
myeloproliferative disorders - metabolism (297) 297
classification (293) 293
survival (293) 293
disease (290) 290
international working group (285) 285
patients (283) 283
chronic myelogenous leukemia (274) 274
jak2 v617f mutation (271) 271
calreticulin - genetics (267) 267
gene expression (264) 264
antineoplastic agents - therapeutic use (263) 263
child (262) 262
therapy (260) 260
acute lymphoblastic-leukemia (259) 259
expression (259) 259
polycythemia (257) 257
protein kinase inhibitors - therapeutic use (257) 257
chronic myeloproliferative disorders (256) 256
disease progression (252) 252
medicine, general & internal (248) 248
medicine (242) 242
development and progression (239) 239
myelodysplastic syndrome (239) 239
dna mutational analysis (236) 236
world-health-organization (233) 233
kinases (231) 231
myelodysplastic syndromes - genetics (229) 229
cells (228) 228
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5975) 5975
German (78) 78
French (65) 65
Chinese (61) 61
Japanese (59) 59
Spanish (38) 38
Russian (34) 34
Polish (18) 18
Hungarian (15) 15
Turkish (11) 11
Korean (10) 10
Czech (6) 6
Italian (6) 6
Portuguese (6) 6
Slovak (3) 3
Croatian (2) 2
Danish (2) 2
Romanian (2) 2
Dutch (1) 1
Hebrew (1) 1
Indonesian (1) 1
Norwegian (1) 1
Persian (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 22, pp. 2168 - 2181
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 13, pp. e609 - e620
Summary Neonatal cancer is rare and comprises a heterogeneous group of neoplasms with substantial histological diversity. Almost all types of paediatric cancer... 
Hematology, Oncology and Palliative Medicine | MESENCHYMAL TUMOR | TRANSIENT MYELOPROLIFERATIVE DISORDER | INTERNATIONAL-SOCIETY | ONCOLOGY | JUVENILE MYELOMONOCYTIC LEUKEMIA | 1ST YEAR | RISK | FETAL | PRENATAL-DIAGNOSIS | BRAIN-TUMORS | CHILDREN | Neoplasms - etiology | Retinoblastoma - therapy | Soft Tissue Neoplasms - diagnosis | Humans | Liver Neoplasms - therapy | Neoplasms - diagnosis | Neuroblastoma - therapy | Maternal Exposure | Neoplasms, Germ Cell and Embryonal - diagnosis | Kidney Neoplasms - diagnosis | Congenital Abnormalities - diagnosis | Neoplasms - complications | Neoplasms - therapy | Neoplasms - genetics | Delivery, Obstetric | Female | Retinoblastoma - diagnosis | Infant, Newborn | Kidney Neoplasms - therapy | Soft Tissue Neoplasms - therapy | Diagnosis, Differential | Genetic Predisposition to Disease | Prenatal Diagnosis | Leukemia - therapy | Central Nervous System Neoplasms - therapy | Neuroblastoma - diagnosis | Interdisciplinary Communication | Liver Neoplasms - diagnosis | Ultrasonography, Prenatal | Urogenital Neoplasms - therapy | Leukemia - diagnosis | Disease Management | Neoplasms - pathology | Central Nervous System Neoplasms - diagnosis | Neoplasms, Germ Cell and Embryonal - therapy | Urogenital Neoplasms - diagnosis | Infants (Newborn) | Genetic disorders | Sarcoma | Pregnant women | Leukemia | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 09/2013, Volume 122, Issue 13, pp. 2176 - 2184
Major causes of morbidity and mortality in myeloproliferative neoplasms are represented by arterial and venous complications, progression to myelofibrosis, and... 
Myeloproliferative Disorders - complications | Thrombosis - etiology | Humans | Risk Factors
Journal Article
by Nand, S
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 895 - 895
Journal Article
Blood, ISSN 0006-4971, 02/2017, Volume 129, Issue 6, pp. 704 - 714
Molecular diagnostics has generated substantial dividends in dissecting the genetic basis of myeloid neoplasms with eosinophilia. The family of diseases... 
GROWTH-FACTOR RECEPTOR | BCR-JAK2 FUSION GENE | MYELOPROLIFERATIVE NEOPLASM | TYROSINE KINASE | TERM-FOLLOW-UP | IDIOPATHIC HYPEREOSINOPHILIC SYNDROME | FIP1L1-PDGFRA FUSION | HEMATOLOGY | SYSTEMIC MASTOCYTOSIS | IMATINIB MESYLATE | PCM1-JAK2 FUSION | Eosinophilia - therapy | Oncogene Proteins, Fusion - metabolism | Leukemia - pathology | Proto-Oncogene Proteins c-abl - antagonists & inhibitors | Humans | Gene Expression Regulation, Neoplastic | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | fms-Like Tyrosine Kinase 3 | Antineoplastic Agents - therapeutic use | Myeloproliferative Disorders - pathology | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Receptor, Platelet-Derived Growth Factor beta - genetics | Myeloproliferative Disorders - genetics | Transplantation, Homologous | Eosinophilia - pathology | Hypereosinophilic Syndrome - diagnosis | Receptor, Platelet-Derived Growth Factor beta - antagonists & inhibitors | Receptor, Platelet-Derived Growth Factor alpha - antagonists & inhibitors | Janus Kinase 2 - metabolism | Eosinophilia - genetics | Hypereosinophilic Syndrome - pathology | Hypereosinophilic Syndrome - therapy | Eosinophilia - diagnosis | Janus Kinase 2 - antagonists & inhibitors | Leukemia - genetics | Receptor, Platelet-Derived Growth Factor beta - metabolism | Myeloproliferative Disorders - diagnosis | Proto-Oncogene Proteins c-abl - genetics | Receptor, Platelet-Derived Growth Factor alpha - metabolism | Myeloproliferative Disorders - therapy | Janus Kinase 2 - genetics | Hematopoietic Stem Cell Transplantation | Leukemia - therapy | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Oncogene Proteins, Fusion - genetics | Protein Kinase Inhibitors - therapeutic use | Receptor, Platelet-Derived Growth Factor alpha - genetics | Leukemia - diagnosis | Proto-Oncogene Proteins c-abl - metabolism | Hypereosinophilic Syndrome - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 894 - 896
To the Editor: In his article on myeloproliferative neoplasms, Spivak (June 1 issue) 1 briefly addresses the diagnostic effect of morphologic features and... 
MEDICINE, GENERAL & INTERNAL | Myeloproliferative Disorders | Mutation | Humans | Neoplasms | Janus Kinase 2 - genetics
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2013, Volume 369, Issue 25, pp. 2379 - 2390
Journal Article